| # | Drug | Count |
|---|---|---|
| 0 | ADALIMUMAB | 7 |
| 1 | LEVETIRACETAM | 7 |
| 2 | LEVETIRACETAM IN SODIUM CHLORIDE | 7 |
| 3 | LEVETIRACETAM INJECTION | 7 |
| 4 | LEVETIRACETAM ORAL | 7 |
| 5 | LAMOTIRIGINE | 6 |
| 6 | LAMOTRIGINE | 6 |
| 7 | LAMOTRIGINE CHEWABLE DISPERSIBLE | 6 |
| 8 | LAMOTRIGINE EXTENDED-RELEASE | 6 |
| 9 | RITONAVIR | 5 |
| # | Drug | Count | Frequency |
|---|---|---|---|
| 0 | CLOMIPHENE CITRATE | 1 | 0.0007 |
| 1 | PROPYLTHIOURACIL | 1 | 0.0005 |
| 2 | NELFINAVIR MESYLATE | 1 | 0.0005 |
| 3 | LAMIVUDINE AND ZIDOVUDINE | 3 | 0.0004 |
| 4 | ZIDOVUDINE | 3 | 0.0003 |
| 5 | ATAZANAVIR | 4 | 0.0003 |
| 6 | RITONAVIR 100 MG | 3 | 0.0002 |
| 7 | ABACAVIR SULFATE, DOLUTEGRAVIR SODIUM, LAMIVUDINE | 1 | 0.0002 |
| 8 | PHENOBARBITAL | 2 | 0.0001 |
| 9 | ELVITEGRAVIR, COBICISTAT, EMTRICITABINE, AND TENOFOVIR DISOPROXIL FUMARATE | 1 | 0.0001 |
| # | Drug class | Count | Frequency |
|---|---|---|---|
| 0 | Protease Inhibitor [EPC] | 6 | 0.0001 |
| 1 | Thyroid Hormone Synthesis Inhibitor [EPC] | 1 | 0.0001 |
| 2 | Cytochrome P450 3A Inhibitor [EPC] | 6 | 0.0001 |
| 3 | Hepatitis B Virus Nucleoside Analog Reverse Transcriptase Inhibitor [EPC] | 4 | 0.0001 |
| 4 | Human Immunodeficiency Virus Nucleoside Analog Reverse Transcriptase Inhibitor [EPC] | 7 | 0.0001 |
| 5 | CD52-directed Cytolytic Antibody [EPC] | 1 | 0.0001 |
| 6 | Mood Stabilizer [EPC] | 7 | 0.0000 |
| 7 | Sympathomimetic-like Agent [EPC] | 1 | 0.0000 |
| 8 | Anti-epileptic Agent [EPC] | 6 | 0.0000 |
| 9 | Pyrimidine Synthesis Inhibitor [EPC] | 1 | 0.0000 |